Sana Biotechnology, Inc. (SANA)

2.815 +0.12 (+4.65%) USD  |  NASDAQ  |  Jun 09, 16:00
2.80 -0.02 (-0.53%) After-Hours: 20:00
More

Sana Biotechnology SG&A Expense (Quarterly) : 11.46M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for SANA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
ImmunityBio, Inc. 45.77M
Sarepta Therapeutics, Inc. 108.95M
Moderna, Inc. 173.00M
Arrowhead Pharmaceuticals, Inc. 41.74M
Oncolytics Biotech, Inc. 4.729M